Literature DB >> 11519483

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

D G Smith1, G J Guillemin, L Pemberton, S Kerr, A Nath, G A Smythe, B J Brew.   

Abstract

Activated macrophages produce quinolinic acid (QUIN), a neurotoxin, in several inflammatory brain diseases including AIDS dementia complex. We hypothesized that IL1-beta, IL6, transforming growth factor (TGF-beta2 and platelet activating factor could increase macrophage QUIN production. And that the HIV-1 proteins Nef, Tat and gp41 may also increase synthesis of QUIN by macrophages. At 72 h there were significant increases in QUIN production in the cells stimulated with PAF (914 +/- 50 nM) and Nef (2781 +/- 162 nM), with somewhat less production by Tat stimulation (645 +/- 240 nM). The increases in QUIN production approximated in vitro concentrations of QUIN shown to be neurotoxic and correlated closely with indoleamine 2,3-dioxygenase induction. IL1-beta, IL6, TGF-beta2 and gp41 stimulation produced no significant increase in QUIN production. These results suggest that some of the neurotoxicity of PAF, nef and tat may be mediated by QUIN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519483     DOI: 10.1080/135502801300069692

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  28 in total

1.  Neurocytotoxity of quinolinic acid in human brain cultures.

Authors:  S J Kerr; P J Armati; B J Brew
Journal:  J Neurovirol       Date:  1995-12       Impact factor: 2.643

2.  Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

Authors:  G Schifitto; N Sacktor; K Marder; M P McDermott; J C McArthur; K Kieburtz; S Small; L G Epstein
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

3.  Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.

Authors:  W Yuan; A Collado-Hidalgo; T Yufit; M Taylor; J Varga
Journal:  J Cell Physiol       Date:  1998-10       Impact factor: 6.384

4.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.

Authors:  A Nath; N J Haughey; M Jones; C Anderson; J E Bell; J D Geiger
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

5.  Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.

Authors:  S J Kerr; P J Armati; L A Pemberton; G Smythe; B Tattam; B J Brew
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

6.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

7.  Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity.

Authors:  D S Magnuson; B E Knudsen; J D Geiger; R M Brownstone; A Nath
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

8.  Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia.

Authors:  A Ranki; M Nyberg; V Ovod; M Haltia; I Elovaara; R Raininko; H Haapasalo; K Krohn
Journal:  AIDS       Date:  1995-09       Impact factor: 4.177

9.  Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis.

Authors:  S W Perry; J A Hamilton; L W Tjoelker; G Dbaibo; K A Dzenko; L G Epstein; Y Hannun; J S Whittaker; S Dewhurst; H A Gelbard
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

Review 10.  Neuropharmacology of quinolinic and kynurenic acids.

Authors:  T W Stone
Journal:  Pharmacol Rev       Date:  1993-09       Impact factor: 25.468

View more
  46 in total

1.  Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.

Authors:  Jianuo Liu; Nan Gong; Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

2.  A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.

Authors:  Chaitali Ghosh; Nicola Marchi; Mohammed Hossain; Peter Rasmussen; Andreas V Alexopoulos; Jorge Gonzalez-Martinez; Hu Yang; Damir Janigro
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

3.  Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains.

Authors:  E M E Burudi; M Cecilia G Marcondes; Debbie D Watry; Michelle Zandonatti; Michael A Taffe; Howard S Fox
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease.

Authors:  Jeremy Hill; Slava Rom; Servio H Ramirez; Yuri Persidsky
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-14       Impact factor: 4.147

6.  Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection.

Authors:  Adriano Boasso; Monica Vaccari; Anna Hryniewicz; Dietmar Fuchs; Janos Nacsa; Valentina Cecchinato; Jan Andersson; Genoveffa Franchini; Gene M Shearer; Claire Chougnet
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Authors:  Adriano Boasso; Monica Vaccari; Dietmar Fuchs; Andrew W Hardy; Wen-Po Tsai; Elzbieta Tryniszewska; Gene M Shearer; Genoveffa Franchini
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

Authors:  Linnéa Asp; Maria Holtze; Susan B Powell; Håkan Karlsson; Sophie Erhardt
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-17       Impact factor: 5.176

9.  Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Authors:  Lars Hagberg; Paola Cinque; Magnus Gisslen; Bruce J Brew; Serena Spudich; Arabella Bestetti; Richard W Price; Dietmar Fuchs
Journal:  AIDS Res Ther       Date:  2010-06-03       Impact factor: 2.250

Review 10.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.